Modern Pediatrics. Ukraine. (2022). 3(123): 27-32. doi 10.15574/SP.2022.123.27
Borуsova T. P., Samsonenko S. V.
Dnipro State Medical University, Ukraine

For citation: Borуsova TP, Samsonenko SV. (2022). Significance of determination of kidney of tubular biomarker KIM-1 in children with juvenile idiopathic arthritis. Modern Pediatrics. Ukraine. 3(123): 27-32. doi 10.15574/SP.2022.123.27.
Article received: Jan 20, 2022. Accepted for publication: Apr 18, 2022.

Renal tubular lesions play an important role in the development and progression of chronic kidney disease (CKD). There has been only one cohort retrospective study of the prevalence of CКD in children with juvenile idiopathic arthritis (JIA). Therefore, early diagnosis of kidney damage using renal biomarkers is important.
Purpose – to determine the frequency and risk factors for the development of structural tubular lesions by studying the level of kidney injury molecule-1 (KIM-1) in the urine of children with JIA, depending on the characteristics of the clinical course of the disease, use of nonsteroidal anti-inflammatory drugs (NSAIDs).
Materials and methods. 80 children from JIA were examined. To measure the marker KIM-1 in urine samples, an enzyme-linked immunosorbent assay was used.
Results. The indicator of the urinary marker KIM-1 in the examined children was 0.997±0.1662 (0.98; 0.90-1.12) ng/ml. High activity of JIA affects the level of urinary KIM-1 – among children with high activity of the disease, 20% had a high level of KIM-1. Involvement of ≥6 joints almost 3-fold increased the in CIdence of elevated urinary KIM-1 levels (OR=5.00; 95% CI: 1.65-15.15; p<0.006). Risk factors for structural tubular kidney lesions in children with JIA were identified: high JIA activity (OR=7.25; 95% CI: 1.22-43.22; p<0.04), arthritis ≥6 joints (OR=5.00; 95% CI: 1.65-15.15; p<0.006), arthritis of the small joints of the hands (OR=4.85; 95% CI: 1.39-16.87; p<0.02), arthritis of the wrist joints (OR=3.78; 95% CI: 1.21-11.83; p<0.03), arthritis of the hip joints (OR=10.41; 95% CI: 1.02-106.7; p<0.05). The level of urinary biomarker KIM-1 was negatively affected by long-term use of NSAIDs (ρ=0.60, p<0.004). An increased level of KIM-1 in urine is associated with hypertension (OR=12.43; 95% CI: 2.26-68.27; p<0.003) and reduced Estimated Glomerular Filtration Rate (eGFR) according to the Hoek formula (OR=15.58; 95% CI: 4.02-60.36; p<0.001), which suggests the presence of CKD in children with JIA as a result of tubular lesions.
Conclusions. Structural damage of the renal tubules, which was established by studying the biomarker KIM-1 in the urine and the relationship with reduced eGFR according to the Hoek formula, suggests the presence of CKD in children with JIA as a result of tubular lesions. Urine KIM-1 testing should be included in the JIA screening plan for early diagnosis of renal disease.
The study was carried out in accordance with the principles of the Helsinki Declaration. The study protocol was approved by the Local Ethics Committee of the institution specified in the work. Informed consent was obtained from the parents of the children for the research.
The authors declare no conflicts of interest.
Key words: juvenile idiopathic arthritis, tubular biomarker KIM-1, children.
REFERENСES

1. Chevalier RL. (2016). The proximal tubule is the primary target of injury and progression of kidney disease: role of the glomerulotubular junction. American journal of physiology. Renal physiology. 311 (1): F145-F161. https://doi.org/10.1152/ajprenal.00164.2016; PMid:27194714 PMCid:PMC4967168

2. De Silva P, Gunasekara T, Gunarathna SD et al. (2021). Urinary Biomarkers of Renal Injury KIM-1 and NGAL: Reference Intervals for Healthy Pediatric Population in Sri Lanka. Children (Basel, Switzerland). 8 (8): 684. https://doi.org/10.3390/children8080684; PMid:34438575 PMCid:PMC8391325

3. Fazel M, Sarveazad A, Mohamed Ali K et al. (2020). Accuracy of Urine Kidney Injury Molecule-1 in Predicting Acute Kidney Injury in Children; a Systematic Review and Meta-Analysis. Archives of academic emergency medicine. 8 (1): e44. PMID: 32309808.

4. Gicchino MF, Di Sessa A, Guarino S et al. (2021). Prevalence of and factors asso95%CIated to chronic kidney disease and hypertension in a cohort of children with juvenile idiopathic arthritis. Eur J Pediatr. 180 (2): 655-661. https://doi.org/10.1007/s00431-020-03792-4; PMid:32860100

5. Gunasekara T, De Silva P, Herath C et al. (2020). The Utility of Novel Renal Biomarkers in Assessment of Chronic Kidney Disease of Unknown Etiology (CKDu): A Review. International journal of environmental research and public health. 17 (24): 9522. https://doi.org/10.3390/ijerph17249522; PMid:33353238 PMCid:PMC7766480

6. Hoek FJ, Kemperman FA, Krediet RT. (2003). A comparison between cystatin C, plasma creatinine and the Cockcroft and Gault formula for the estimation of glomerular filtration rate. Nephrol Dial Transplant. 18 (10): 2024-2031. https://doi.org/10.1093/ndt/gfg349; PMid:13679476

7. KDIGO. (2013). Kidney Disease: Improving Global Outcomes CKD Work Group. KDIGO 2012 Clinical Practice Guideline for the Evaluation and Management of Chronic Kidney Disease. Kidney International Supplements. 3 (1): 1-50. URL: https://kdigo.org/wp-content/uploads/2017/02/KDIGO_2012_CKD_GL.pdf.

8. Kirk R. (2013). Renal fibrosis: KIM-1 expression links kidney injury with CKD in mice. Nat Rev Nephrol. 9 (11): 627. https://doi.org/10.1038/nrneph.2013.194; PMid:24042465

9. Kochi M, Kohagura K, Shiohira Y et al. (2016). Inflammation as a Risk of Developing Chronic Kidney Disease in Rheumatoid Arthritis. PLoS One. 11 (8): e0160225. https://doi.org/10.1371/journal.pone.0160225; PMid:27537204 PMCid:PMC4990299

10. Miyamae T, Tani Y, Kishi T et al. (2020). Updated version of Japanese Childhood Health Assessment Questionnaire (CHAQ). Mod Rheumatol. 30 (5): 905-909. https://doi.org/10.1080/14397595.2019.1660027; PMid:31441680

11. Nordal EB, Zak M, Berntson L et al. (2011). Juvenile Arthritis Disease Activity Score (JADAS) based on CRP; validity and predictive ability in a Nordic population-based setting. Pediatr Rheumatol Online J. 9 (1): 155. https://doi.org/10.1186/1546-0096-9-S1-P155; PMCid:PMC3194508

12. Ringold S, Angeles-Han ST, Beukelman T et al. (2019). 2019 American College of Rheumatology / Arthritis Foundation Guideline for the Treatment of Juvenile Idiopathic Arthritis: Therapeutic Approaches for Non-Systemic Polyarthritis, Sacroiliitis, and Enthesitis. Arthritis Care Res (Hoboken). 71 (6): 717-734. https://doi.org/10.1002/acr.23870; PMid:31021516 PMCid:PMC6561125

13. Sandokji I, Greenberg JH. (2020). Novel biomarkers of acute kidney injury in children: an update on recent findings. Curr Opin Pediatr. 32 (3): 354-359. https://doi.org/10.1097/MOP.0000000000000891; PMid:32332324

14. Schnaper HW. (2017). The Tubulointerstitial Pathophysiology of Progressive Kidney Disease. Advances in chronic kidney disease. 24 (2): 107-116. https://doi.org/10.1053/j.ackd.2016.11.011; PMid:28284376 PMCid:PMC5351778

15. Shao X, Tian L, Xu W et al. (2014). Diagnostic Value of Urinary Kidney Injury Molecule 1 for Acute Kidney Injury: A Meta-Analysis. PLOS ONE. 9 (1): e84131. https://doi.org/10.1371/journal.pone.0084131; PMid:24404151 PMCid:PMC3880280

16. Song J, Yu J, Prayogo GW et al. (2019). Understanding kidney injury molecule 1: a novel immune factor in kidney pathophysiology. Am J Transl Res. 11 (3): 1219-1229. PMID: 30972157.